Cargando…
COVID-19-associated pulmonary aspergillosis (CAPA): how big a problem is it?
Autores principales: | Fekkar, Arnaud, Neofytos, Dionysios, Nguyen, Minh-Hong, Clancy, Cornelius J., Kontoyiannis, Dimitrios P., Lamoth, Frederic |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275029/ https://www.ncbi.nlm.nih.gov/pubmed/34192575 http://dx.doi.org/10.1016/j.cmi.2021.06.025 |
Ejemplares similares
-
COVID-19-Associated Pulmonary Aspergillosis (CAPA)
por: Dimopoulos, George, et al.
Publicado: (2021) -
Two cases of COVID‐19‐associated pulmonary aspergillosis (CAPA)
por: Lim, Jin Lee, et al.
Publicado: (2022) -
COVID-19 Associated Pulmonary Aspergillosis (CAPA)—From Immunology to Treatment
por: Arastehfar, Amir, et al.
Publicado: (2020) -
COVID-19 associated pulmonary aspergillosis (CAPA): An Australian case report
por: Sharma, Avinash, et al.
Publicado: (2020) -
COVID-19 associated pulmonary aspergillosis (CAPA) in a pregnant woman
por: Agrawal, Shruti, et al.
Publicado: (2021)